Total Ideas
1
Bullish Ideas
0 (0%)
Bearish Ideas
Recent Activity
0
"ACRS: Small-cap biotech at $2.44/share, $174M mkt cap vs $122M net cash. KINect platform for drug discovery. Growing revenue, multiple drugs in pipeline. Trading close to cash value. Potential upside but risky due to small-cap biotech nature."
Sentiment